Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSome people do report putting on weight with Mounjaro, and it is more common than the headlines suggest. Tirzepatide is a prescription-only medicine that reduces appetite through two gut-hormone pathways, yet weight gain during treatment is a real experience for a minority of people — and it has specific, identifiable causes. These are prescription-only medicines; a GPhC-registered prescriber decides whether they are clinically suitable for you, and understanding what can drive the scales upward helps that conversation go further. Below, our clinical team at nume explains what the evidence and prescribing experience actually show.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
It sounds contradictory, and that is exactly why people find it alarming. The truth is that putting weight on with Mounjaro, while uncommon, happens for reasons that are almost always traceable. Tirzepatide works by activating both GIP and GLP-1 receptors, two signals the body uses to regulate appetite and blood-sugar response. In clinical trials involving thousands of adults, average body-weight reductions were substantial at higher doses. But averages are not everyone's story.
The most frequent explanation is calorie compensation. When nausea is prominent in the first few weeks, some people eat very little. Once the side effects settle, appetite can briefly rebound before the medicine's full suppressive effect takes hold, and food intake can creep back up faster than people realise. A second contributor is fluid retention: changes in carbohydrate intake alter glycogen stores, and glycogen holds water, the scale can rise a kilogram or two without any meaningful change in body fat. This is especially common around dose transitions.
A third factor is muscle. If protein intake falls too low on a reduced-calorie diet, the body draws on lean tissue. Fat loss continues, but lean mass disappears too, and that shift can show as a smaller net weight loss or even a brief gain on a simple bathroom scale. This is one reason our prescribers discuss protein adequacy as part of treatment from the start. If you are unsure what is driving a change, the detailed breakdown of why weight goes up on Mounjaro covers the individual causes in more depth.
Sometimes, yes. Treatment begins at 2.5 mg, a starting point designed to let your system adjust, not to produce significant weight loss at that level. Some people expect movement on the scales immediately and worry when it does not come, or when their weight fluctuates, and if you are wondering whether it is actually possible to put weight on with Mounjaro, the answer depends on a number of individual factors worth understanding. Titration typically happens in four-week steps under your prescriber's guidance, and the appetite-suppressing effect strengthens as the dose increases.
If someone stays at a lower dose for longer than expected, or if a dose increase has been delayed, the reduced suppression of appetite can mean eating patterns slip back. That is not the same as the medicine failing; it is a timing issue. It is also worth knowing that certain medicines taken alongside Mounjaro can affect how the body processes food and fluid. Steroids, some antidepressants, and medicines for blood pressure are common examples. Any change in a co-prescribed medicine should go straight to your prescriber's attention, not a forum, not a pharmacist working from memory.
For context on how Mounjaro is expected to affect weight across treatment, the NHS's patient information on tirzepatide sets out what the medicine is and is not designed to do, which can help frame realistic expectations. You can also read more about how Mounjaro affects weight across different stages of treatment.
Rarely, on its own. A single week of higher readings, water-retention fluctuation, or a gain during a stressful period is not evidence that tirzepatide has stopped working. The clinical picture over weeks and months matters far more than one weigh-in. What is worth acting on: a sustained upward trend over several consecutive weeks, a gain that coincides with a change in another medicine, or weight gain accompanied by symptoms that feel new or unusual. If you have noticed a pattern and want to understand the specific reasons behind it, our guide on why you may have put weight on with Mounjaro works through the most common causes in detail.
There is a specific and important scenario to be aware of: weight that returns after stopping treatment. That is a different question from gaining weight during treatment, and it has its own answers, if this is your concern, the page on putting weight on after Mounjaro addresses it directly. If you are currently on treatment and the scales are going the wrong way, the first step is a conversation with your prescriber, not a dose change you initiate yourself.
At nume (sorry, at nume) every repeat order includes a clinical review before anything is dispatched. That review exists precisely for moments like this: so a prescriber can look at what is happening, ask the right questions, and adjust the plan if needed. If cost is also on your mind while navigating treatment decisions, the Mounjaro price comparison guide puts the UK private market in context without any sales pitch.
Mounjaro is a prescription-only medicine. Whether your question is about weight on the scales, a side effect you did not expect, or whether treatment is still right for you, those conversations belong with a prescriber. Check your eligibility and speak to our clinical team.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.